Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy
Udo F. H. Engelke, Rianne E. van Outersterp, Jona Merx, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 15
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

How to proceed after “negative” exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques
Saskia B. Wortmann, Machteld M. Oud, Mariëlle Alders, et al.
Journal of Inherited Metabolic Disease (2022) Vol. 45, Iss. 4, pp. 663-681
Open Access | Times Cited: 56
Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets
Jie Xia, Siqin Li, Suling Liu, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 41
Multi-omics integration and epilepsy: Towards a better understanding of biological mechanisms
Debbie Chong, Nigel C. Jones, Ralf B. Schittenhelm, et al.
Progress in Neurobiology (2023) Vol. 227, pp. 102480-102480
Open Access | Times Cited: 18
Association Between Lysine Reduction Therapies and Cognitive Outcomes in Patients With Pyridoxine-Dependent Epilepsy
Curtis R. Coughlin, Laura A. Tseng, Levinus A. Bok, et al.
Neurology (2022) Vol. 99, Iss. 23
Open Access | Times Cited: 21
Inclusion of pyridoxine dependent epilepsy in expanded newborn screening programs by tandem mass spectrometry: set up of first and second tier tests
Roberta Damiano, Maria Della Bona, Elena Procopio, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2025)
Closed Access
Identification and enrichment of potential pathways in the buffy coat of patients with DRE using non-targeted metabolomics integrated with GEO Datasets
Hailin Zhu, Suyue Zheng, Liyuan Xie, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Metabolite Identification Using Infrared Ion Spectroscopy─Novel Biomarkers for Pyridoxine-Dependent Epilepsy
Rianne E. van Outersterp, Udo F. H. Engelke, Jona Merx, et al.
Analytical Chemistry (2021) Vol. 93, Iss. 46, pp. 15340-15348
Open Access | Times Cited: 24
Targeted Small-Molecule Identification Using Heartcutting Liquid Chromatography–Infrared Ion Spectroscopy
Rianne E. van Outersterp, J.M.A. van Oosterhout, Christoph Gebhardt, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 6, pp. 3406-3413
Open Access | Times Cited: 10
Pyridoxine‐dependent epilepsy: Current perspectives and questions for future research
Curtis R. Coughlin, Sídney M. Gospe
Annals of the Child Neurology Society (2023) Vol. 1, Iss. 1, pp. 24-37
Open Access | Times Cited: 10
Assessment of urinary 6‐oxo‐pipecolic acid as a biomarker for ALDH7A1 deficiency
Youssef Khalil, Emma Footitt, Sreekanth Vootukuri Reddy, et al.
Journal of Inherited Metabolic Disease (2024)
Open Access | Times Cited: 3
Metabolomics in diagnostics of inborn metabolic disorders
Judith Jans, Melissa H. Broeks, Nanda M. Verhoeven‐Duif
Current Opinion in Systems Biology (2021) Vol. 29, pp. 100409-100409
Open Access | Times Cited: 19
Personalized medicine for rare neurogenetic disorders: can we make it happen?
Agnies M. van Eeghen, Hilgo Bruining, Nicole I. Wolf, et al.
PubMed (2022) Vol. 8, Iss. 2
Closed Access | Times Cited: 13
Novel cerebrospinal fluid biomarkers of glucose transporter type 1 deficiency syndrome: Implications beyond the brain's energy deficit
Tessa M. A. Peters, Jona Merx, Pieter C. Kooijman, et al.
Journal of Inherited Metabolic Disease (2022) Vol. 46, Iss. 1, pp. 66-75
Open Access | Times Cited: 13
Evaluation of table-top lasers for routine infrared ion spectroscopy in the analytical laboratory
Rianne E. van Outersterp, Jonathan Martens, A. Peremans, et al.
The Analyst (2021) Vol. 146, Iss. 23, pp. 7218-7229
Open Access | Times Cited: 16
Chemically-induced epileptic seizures in zebrafish: A systematic review
Rafael Chitolina, Matheus Gallas‐Lopes, Carlos G. Reis, et al.
Epilepsy Research (2023) Vol. 197, pp. 107236-107236
Open Access | Times Cited: 6
Restricting lysine normalizes toxic catabolites associated with ALDH7A1 deficiency in cells and mice
Amritpal S. Johal, Hilal H. Al-Shekaili, Muna Abedrabbo, et al.
Cell Reports (2024) Vol. 43, Iss. 12, pp. 115069-115069
Closed Access | Times Cited: 2
Metabolomics-Based Screening of Inborn Errors of Metabolism: Enhancing Clinical Application with a Robust Computational Pipeline
Brechtje Hoegen, Alan Zammit, Albert W. Gerritsen, et al.
Metabolites (2021) Vol. 11, Iss. 9, pp. 568-568
Open Access | Times Cited: 15
An In Silico Infrared Spectral Library of Molecular Ions for Metabolite Identification
Kas J. Houthuijs, Giel Berden, Udo F. H. Engelke, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 23, pp. 8998-9005
Open Access | Times Cited: 6
On pathways and blind alleys—The importance of biomarkers in vitamin B6‐dependent epilepsies
Barbara Plecko
Journal of Inherited Metabolic Disease (2023) Vol. 46, Iss. 5, pp. 839-847
Open Access | Times Cited: 4
Succinic semialdehyde dehydrogenase deficiency in mice and in humans: An untargeted metabolomics perspective
Tessa M. A. Peters, Udo F. H. Engelke, Siebolt de Boer, et al.
Journal of Inherited Metabolic Disease (2023) Vol. 47, Iss. 3, pp. 417-430
Open Access | Times Cited: 4
Update current understanding of neurometabolic disorders related to lysine metabolism
Fu-Man Chang
Epilepsy & Behavior (2023) Vol. 146, pp. 109363-109363
Closed Access | Times Cited: 4
Identification of organic micro-pollutants in surface water using MS-based infrared ion spectroscopy
Kas J. Houthuijs, M. J. Horn, Dennis Vughs, et al.
Chemosphere (2023) Vol. 341, pp. 140046-140046
Open Access | Times Cited: 4
Dietary management for pyridoxine‐dependent epilepsy due to α‐aminoadipic semialdehyde dehydrogenase deficiency, a follow‐on from the international consortium guidelines
Marjorie Dixon, Chloe Millington, Laurie Bernstein, et al.
JIMD Reports (2024) Vol. 65, Iss. 3, pp. 188-203
Open Access | Times Cited: 1
Precision diagnosis and treatment of vitamin metabolism-related epilepsy
Yajing Gan, Guoyan Li, Zihan Wei, et al.
Acta Epileptologica (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Feasibility of newborn screening for pyridoxine-dependent epilepsy
Kristine Pauly, Michael Woontner, José E. Abdenur, et al.
Molecular Genetics and Metabolism (2024) Vol. 144, Iss. 1, pp. 109002-109002
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top